Medicine and Dentistry
Randomized Controlled Trial
100%
Systematic Review
98%
Asthma
78%
Primary Health Care
61%
Meta-Analysis
51%
Health Care Cost
45%
Disease
37%
Chronic Obstructive Pulmonary Disease
37%
Apoplexy
37%
Cohort Analysis
32%
Quality of Life
30%
Cost-Effectiveness Analysis
30%
Odds Ratio
29%
Malignant Neoplasm
29%
Observational Study
21%
Clinician
21%
COVID-19
20%
Drug Therapy
20%
Prevalence
19%
Severe Asthma
18%
Clinical Trial
18%
Surgery
17%
Prostate Cancer
16%
Arm
15%
Adverse Event
13%
Comorbidity
13%
Health Care
13%
Stress Incontinence
13%
Diagnosis
12%
Body Mass Index
12%
General Practitioner
12%
Secondary Care
12%
General Medicine
12%
Placebo
11%
Gene Linkage
11%
Brain Ischemia
11%
Medicine
11%
Hazard Ratio
11%
Quality Adjusted Life Year
10%
Cohort Effect
10%
Patient Referral
10%
Logistic Regression Analysis
10%
Physical Activity
10%
In Vitro Fertilisation
10%
Melanoma
9%
Surgeon
9%
Biological Product
9%
Obstetrics
9%
Cardiovascular Disease
9%
Consultation
8%
Urology
8%
Public Health
8%
Allergic Rhinitis
8%
Spondylarthritis
8%
Vitamin D
8%
Infection
8%
Chronic Kidney Disease
8%
Prospective Cohort Study
8%
Embryo Transfer
8%
Health Service
8%
Patient Care
8%
Physician
8%
Base
8%
Incentive
7%
Decision Making
7%
National Health Service
7%
Premature Labor
7%
Lung
7%
Patient with Asthma
7%
Behavioral Change
7%
Cross Sectional Study
7%
Pediatrics
7%
Rheumatology
7%
Recurrent Disease
7%
Mental Health
7%
Injury
7%
Assisted Reproductive Technology
7%
Parasympatholytic
7%
Supplementation
7%
Weight Management
7%
Retrospective Cohort Study
7%
Diabetes
7%
Biological Marker
6%
Population
6%
Intracytoplasmic Sperm Injection
6%
Frailty
6%
Breast Cancer
6%
Care Pathway
6%
Health Status
6%
Spontaneous Abortion
6%
Cesarean Section
6%
Colorectal Carcinoma
6%
Cerebral Hemorrhage
6%
Patient-Reported Outcome
6%
Conception
6%
Conservative Treatment
6%
Health Outcomes
6%
Adverse Outcome
5%
Cardiovascular System
5%
Chronic Pain
5%
Nursing and Health Professions
Systematic Review
57%
Primary Medical Care
44%
Asthma
33%
Confidence Interval
31%
Practice Guideline
23%
Health Care Personnel
23%
Cerebrovascular Accident
22%
Cost Effectiveness Analysis
22%
Obstructive Lung Disease
22%
Meta Analysis
22%
Quality of Life
20%
Disease
20%
Health Service
20%
Malignant Neoplasm
18%
Odds Ratio
18%
Drug Therapy
17%
General Practitioner
14%
Prevalence
14%
Physician
14%
Cohort Analysis
14%
Health Practitioner
11%
Hospital
11%
General Practice
9%
Body Mass
9%
Quality Adjusted Life Year
9%
Patient Referral
9%
Surgery
8%
Economic Evaluation
8%
Clinical Practice
8%
Logistic Regression Analysis
8%
Secondary Health Care
8%
Cochrane Library
8%
Base
7%
Chronic Pain
7%
Self Care
7%
Randomization
7%
Clinical Audit
7%
Health Status
7%
Nutrition Policy
6%
Stress Incontinence
6%
Cross-Sectional Study
6%
Clinical Effectiveness
6%
Cardiovascular Disease
6%
Socialized Medicine
6%
Diagnosis
6%
Prostate Cancer
6%
Brain Ischemia
6%
Patient Care
6%
Melanoma
5%
Pharmacy
5%
Health Outcomes
5%
Mental Health
5%
Inhaler
5%
CINAHL
5%
Length of Stay
5%
Spondylarthritis
5%
Cholinergic Receptor Blocking Agent
5%
Dry Powder Inhaler
5%
Comorbidity
5%
Analgesia
5%
Maternal Mortality
5%
Keyphrases
Asthma
30%
Randomized Controlled Trial
27%
Scotland
22%
Confidence Interval
21%
Meta-analysis
17%
Primary Care
15%
Systematic Meta-analysis
13%
Severe Asthma
12%
Chronic Obstructive Pulmonary Disease
12%
Discrete Choice Experiment
11%
Scottish
10%
Odds Ratio
10%
Comorbidity
9%
Chronic Pain
9%
Cost-effectiveness
9%
Randomized Trial
8%
Inhaled Corticosteroids
8%
Oral Corticosteroids
7%
Healthcare Professionals
7%
Clinical Trials
7%
Risk Factors
6%
COVID-19
6%
Healthcare
6%
Quality of Life
5%
Norfolk
5%
Willingness to Pay
5%
High Risk
5%
Prospective Cohort Study
5%
Prostate Cancer
5%
Economic Evaluation
5%
Core Outcome Set
5%